John Bond Joins Physician Recommended Nutriceuticals (PRN) as Senior Vice President of Operations

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) March 23, 2011 -- In his new position, Bond will supervise all of the company’s day-to-day operations as well as provide oversight and guidance for PRN’s financial functions.
“We are very excited to welcome John Bond to PRN,” said PRN’s CEO Ken Krieg. “He brings 30 years of experience in the life science field – a tremendous asset to the company during a period of rapid growth.”

Bond, a Scottish Chartered Accountant, has served as CFO for Cytokine PharmaSciences and Biotechnology General Inc. (now Savient Pharmaceuticals). At Cytokine, he took to market a business seeking equity investment as well as debt funding. He also served as Managing Director for the company’s manufacturing and R&D subsidiary in Scotland.
While working with Rhone-Poulenc Rorer, Bond was appointed CFO of Centeon, the $1 billion joint venture between Rhone-Poulenc and Hoechst engaged in the manufacturing, research and development and sales of therapeutic plasma proteins.
According to Bond, the uniqueness of PRN’s business model and value proposition in the marketplace piqued his interest in joining the PRN team. “I am very excited about PRN’s future and happy to be a part of it,” Bond stressed.

John Bond     Physician Recommended Nutriceu     PRN